The calcium supplement industry in Japan is expected to develop at a CAGR of 10.0% through 2033. The demand for calcium supplement in Japan is expected to grow significantly, reaching US$ 153.3 million in 2023.
The contemporary generation's holistic attitude to health and well-being has spurred solutions that address issues ranging from dietary inadequacies to lifestyle disorders. Therefore, the calcium supplement industry in Japan is anticipated to be worth US$ 395.8 million by 2033.
Key Highlights:
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2023) | US$ 153.3 million |
| Anticipated Forecast Value (2033) | US$ 395.8 million |
| Estimated Growth (2023 to 2033) | 10.0% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Attributes | Details |
|---|---|
| Form | Soft Gel Pills |
| Industry Share in 2023 | 49.8% |
| Attributes | Details |
|---|---|
| End Use | Men |
| Industry Share in 2023 | 39.5% |
Principal Consultant
The competitive landscape of the calcium supplement industry in Japan is quickly expanding, owing to an aging population, increased health consciousness, and a growing desire for self-care. Leading companies in the Japan calcium supplement industry include Eisai, Morinaga Milk Industry, UNIMAT RIKEN, ORIHIRO, Asahi Group, Otsuka, DHC, Bean Stalk Snow, Dainippon Pharmaceutical, and Kobayashi Pharmaceutical.
These firms offer a wide range of calcium supplements, catering to various customer sectors and demands. The industry in Japan is predicted to experience further growth in the future years. New product innovations, such as calcium supplements with additional nutrients or functional components, are also anticipated to impact the industry.
Recent Developments in the Calcium Supplement Industry in Japan
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Estimated Valuation (2023) | US$ 153.3 million |
| Projected Valuation (2033) | US$ 395.8 million |
| Anticipated CAGR (2023 to 2033) | 10.0% CAGR |
| Historical Analysis of Calcium Supplement in Japan | 2018 to 2022 |
| Demand Forecast for Calcium Supplement in Japan | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Industry Size, Industry Trends, Key Insights for Calcium supplement Adoption in Japan, Insights on Global Players and Leading Industry Strategy in Japan, Ecosystem Analysis of Local and Regional Industry. |
| Key Companies Profiled | Eisai Company, Ltd.; Morinaga Milk Industry; Dainippon Pharmaceutical; Kobayashi Pharmaceutical; Rohto Pharmaceutical Co.; Daiwa Pharmaceutical Co.; Kyowa Hakko Bio Co., Ltd.; Suntory Beverage & Food Limited; UNIMAT RIKEN; ORIHIRO; Asahi Group; Otsuka; DHC; Bean Stalk Snow |
The anticipated CAGR for the Japan calcium supplement industry through 2033 is 10.0%.
Demand for calcium supplement in Japan is likely to surpass US$ 395.8 million by 2033.
In 2023, the industry size of the calcium supplement in Japan is anticipated to be US$ 153.3 million.
Soft gel pills are the preferred form of calcium supplement in Japan, with an industry share of 49.8%.
In Japan, male population dominates the calcium supplement industry, with a share of 39.5%.
1. Executive Summary
1.1. Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Gummy
5.3.2. Pill
5.3.3. Capsule
5.3.4. Liquid
5.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Product, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Product, 2023 to 2033
6.3.1. Calcium Carbonate
6.3.2. Calcium Gluconate
6.3.3. Calcium Citrate
6.3.4. Calcium Lactate
6.3.5. Calcium Phosphate
6.3.6. Calcium Orotate
6.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Applications
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Applications, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Applications, 2023 to 2033
7.3.1. Adult
7.3.2. Children
7.4. Y-o-Y Growth Trend Analysis By Applications, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Applications, 2023 to 2033
8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2023 to 2033
8.3.1. Kanto
8.3.2. Chubu
8.3.3. Kinki
8.3.4. Kyushu & Okinawa
8.3.5. Tohoku
8.3.6. Rest of
8.4. Market Attractiveness Analysis By Region
9. Kanto Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Type
9.2.2. By Product
9.2.3. By Applications
9.3. Market Attractiveness Analysis
9.3.1. By Type
9.3.2. By Product
9.3.3. By Applications
9.4. Key Takeaways
10. Chubu Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Type
10.2.2. By Product
10.2.3. By Applications
10.3. Market Attractiveness Analysis
10.3.1. By Type
10.3.2. By Product
10.3.3. By Applications
10.4. Key Takeaways
11. Kinki Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Type
11.2.2. By Product
11.2.3. By Applications
11.3. Market Attractiveness Analysis
11.3.1. By Type
11.3.2. By Product
11.3.3. By Applications
11.4. Key Takeaways
12. Kyushu & Okinawa Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Type
12.2.2. By Product
12.2.3. By Applications
12.3. Market Attractiveness Analysis
12.3.1. By Type
12.3.2. By Product
12.3.3. By Applications
12.4. Key Takeaways
13. Tohoku Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Type
13.2.2. By Product
13.2.3. By Applications
13.3. Market Attractiveness Analysis
13.3.1. By Type
13.3.2. By Product
13.3.3. By Applications
13.4. Key Takeaways
14. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Type
14.2.2. By Product
14.2.3. By Applications
14.3. Market Attractiveness Analysis
14.3.1. By Type
14.3.2. By Product
14.3.3. By Applications
14.4. Key Takeaways
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Type
15.3.3. By Product
15.3.4. By Applications
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Otsuka Pharmaceutical Co., Ltd.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Morishita Jintan Co., Ltd
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Umeken
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Pfizer (Caltrate)
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. AandZ Pharmaceutical
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Amway(Nutrilite)
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Shanxi Zhendong Pharmaceutical Co., Ltd.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Nature Made
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. By-health Co., Ltd.
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Harbin Pharmaceutical Group
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Food and Beverage Insights
View Reports
Demand and Trend Analysis of Calcium Supplement in Japan
